Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review: Clinical Studies

Alessandro Villa; Bryan J. Schneider; Christina Lacchetti; Thomas K. Oliver; Douglas E. Peterson

doi:10.1038/s41416-024-02933-y

Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review: Clinical Studies

Alessandro Villa
, Bryan J. Schneider
, Christina Lacchetti
, Thomas K. Oliver
, Douglas E. Peterson

Baptist Health South Florida

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	49-50
Number of pages	2
Journal	British Journal of Cancer
Volume	132
Issue number	1
DOIs	https://doi.org/10.1038/s41416-024-02933-y
State	Published - Jan 31 2025

ASJC Scopus Subject Areas

Oncology
Cancer Research

Access to Document

10.1038/s41416-024-02933-y

Cite this

Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review: Clinical Studies. / Villa, Alessandro; Schneider, Bryan J.; Lacchetti, Christina et al.
In: British Journal of Cancer, Vol. 132, No. 1, 31.01.2025, p. 49-50.

Research output: Contribution to journal › Comment/debate › peer-review

@article{304537169adb429aaace413a1240080b,

title = "Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review: Clinical Studies",

author = "Alessandro Villa and Schneider, \{Bryan J.\} and Christina Lacchetti and Oliver, \{Thomas K.\} and Peterson, \{Douglas E.\}",

year = "2025",

month = jan,

day = "31",

doi = "10.1038/s41416-024-02933-y",

language = "English",

volume = "132",

pages = "49--50",

journal = "British Journal of Cancer",

issn = "0007-0920",

number = "1",

}

TY - JOUR

T1 - Commentary to

T2 - Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review: Clinical Studies

AU - Villa, Alessandro

AU - Schneider, Bryan J.

AU - Lacchetti, Christina

AU - Oliver, Thomas K.

AU - Peterson, Douglas E.

PY - 2025/1/31

Y1 - 2025/1/31

UR - https://www.scopus.com/pages/publications/85212190250

UR - https://www.scopus.com/pages/publications/85212190250#tab=citedBy

U2 - 10.1038/s41416-024-02933-y

DO - 10.1038/s41416-024-02933-y

M3 - Comment/debate

C2 - 39681618

AN - SCOPUS:85212190250

SN - 0007-0920

VL - 132

SP - 49

EP - 50

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 1

ER -

Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review: Clinical Studies

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this